Skip to content
KAMURAROOTED IN WELLNESS
Repair & inflammation / VISUAL FIELD GUIDE

KPV

KPV is a three-amino-acid peptide studied for inflammatory signalling in gut cells and animal colitis models.

01 / FOLLOW THE BIOLOGY

From signal to response.

CELL & TISSUE RESPONSESchematic explanation · not a measured treatment response
STEP 1 OF 3

Cell uptake

A transporter can carry the small peptide into cells.

Pathway sources: [1] [2]

02 / SYMPTOMS & STUDIED USES

What are you trying to understand?

Choose a concern to see the research context. A symptom is a starting point for assessment, not a treatment selection.

Cell and animal research

Bowel inflammation

KPV reduced inflammatory signalling and colitis measures in experimental models.

Examine the supporting research ↓
03 / KEEP THE CONTEXT

The details that change the interpretation.

Formulation & route

Study delivery systems include experimental oral preparations and nanoparticles; routine capsules or injections need their own evidence.

Bring to the discussion

Is there a human trial measuring symptoms and mucosal healing for this exact preparation?

04 / SOURCE TRAIL

Go beyond the summary.

More research already linked in Kamura (4)

Self-Cross-Linked Hydrogel of Cysteamine-Grafted γ-Polyglutamic Acid Stabilized Tripeptide KPV for Alleviating TNBS-Induced Ulcerative Colitis in Rats. · 2021

Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis. · 2017

Critical role of PepT1 in promoting colitis-associated cancer and therapeutic benefits of the anti-inflammatory PepT1-mediated tripeptide KPV in a murine model. · 2016

PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. · 2008

My Stack

0 treatments

🧪

Your stack is empty. Browse treatments and click + to build your protocol.